MedPath

Study for integrated traditional Chinese and western medicine in the treatment of the polyuria and recovery period of epidemic hemorrhagic fever

Phase 1
Conditions
Epidemic hemorrhagic fever(Hemorrhagic fever with renal syndrome)
Registration Number
ITMCTR1900002770
Lead Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Comply with the diagnostic criteria for epidemic hemorrhagic fever;
(2) hypotension shock and/or renal failure oliguria (greater than 5 days) in the acute phase;
(3) Currently entering the epidemic hemorrhagic fever polyuria period: 24h urine volume > 2000ml;
(4) Comply with the diagnostic criteria of TCM syndrome (syndrome of lingering pathogen due to deficient vital qi);
(5) The age range is between 18 and 70 years old;
(6) Voluntarily accept the treatment plan and sign the informed consent form.

Exclusion Criteria

(1) an overdue patient who has not experienced a shock/oliguria;
(2) Patients with abnormal liver function (ASK, ALT exceeds the upper limit of 1.5 times);
(3) Those who cannot take Chinese medicine due to diseases such as gastrointestinal bleeding;
(4) Combine severe heart, cerebrovascular and liver, kidney, hematopoietic diseases, and mental patients;
(5) Oral treatment with Chinese medicine within 4 weeks;
(6) Pregnant, pregnant or lactating women;
(7) With history of allergic reactions to related drugs.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recovery period (recovery time for kidney damage, blood pressure and anemia);
Secondary Outcome Measures
NameTimeMethod
TCM symptom score;
© Copyright 2025. All Rights Reserved by MedPath